[1]
L. Gorobets and A. Litvinov, “CARIPRAZINE: NEUROENDOCRINE AND METABOLIC ASPECTS OF TOLERANCE IN PATIENTS WITH MENTAL DISORDERS”, СТПР, no. 3, pp. 19–27, Sept. 2020.